ALCHEMAB
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79403954
- Registration number
- 8026498
- Mark type
- Stylized text
- Filed
- 03 Jul 2024
- Published for opposition
- 30 Sept 2025
- Registered
- 18 Nov 2025
- Attorney of record
- James M. Theo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations incorporating antibodies for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; pharmaceutical preparations incorporating antibody technology for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; chemical preparations for medical and pharmaceutical purposes incorporating antibodies for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; Chemical preparations for medical and pharmaceutical purposes incorporating antibody technology for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; antibodies for medical purposes; diagnostic preparations involving the testing and identification of antibodies for medical purposes; diagnostic preparations involving the testing of antibodies for medical purposes; diagnostic preparations involving the identification of antibodies for medical purposes.
- Class 009 — Scientific and electric apparatus: Downloadable software for the testing of antibodies; downloadable software for the identification of antibodies; downloadable software for use in development of pharmaceutical preparations incorporating antibodies; downloadable software for use in development of pharmaceutical preparations incorporating antibody technology.
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies and antibody technology; drug development and discovery services in relation to pharmaceutical preparations incorporating antibodies and antibody technology; antibody discovery services in the nature of drug discovery services; development and testing of computing methods, algorithms and software for the testing and identification of antibodies; development and testing of computing methods, algorithms and software in the field of antibody technology; development and testing of computing methods, algorithms and software for use in or relating to the development of pharmaceutical preparations incorporating antibodies and antibody technology; information, advisory and consultancy services in relation to all of the aforesaid.
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic services involving the testing of antibodies for medical purposes; medical diagnostic services involving the identification of antibodies for medical purposes; medical testing, analysis and diagnostic services in the field of antibodies; information, advisory and consultancy services in relation to all of the aforesaid.
Owner
- Alchemab Therapeutics Ltd, London, GB
- Alchemab Therapeutics Ltd, London N1C 4AX, GB
- Alchemab Therapeutics Ltd, London N1C 4AX, GB
Prosecution history
- 23 Mar 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
- 09 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 18 Feb 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 09 Dec 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Sept 2025 — PUBLISHED FOR OPPOSITION
- 24 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 28 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED